These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1664721)

  • 1. Attenuated revertant serotype 1 Marek's disease viruses: safety and protective efficacy.
    Witter RL
    Avian Dis; 1991; 35(4):877-91. PubMed ID: 1664721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New serotype 2 and attenuated serotype 1 Marek's disease vaccine viruses: selected biological and molecular characteristics.
    Witter RL; Silva RF; Lee LF
    Avian Dis; 1987; 31(4):829-40. PubMed ID: 2831870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New serotype 2 and attenuated serotype 1 Marek's disease vaccine viruses: comparative efficacy.
    Witter RL
    Avian Dis; 1987; 31(4):752-65. PubMed ID: 2831867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyvalent Marek's disease vaccines: safety, efficacy and protective synergism in chickens with maternal antibodies.
    Witter RL; Lee LF
    Avian Pathol; 1984 Jan; 13(1):75-92. PubMed ID: 18766823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of CVI988/Rispens and R2/23, two prototype vaccine strains of serotype 1 Marek's disease virus.
    Witter RL; Lee LF; Fadly AM
    Avian Dis; 1995; 39(2):269-84. PubMed ID: 7677647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotype specificity of B-haplotype influence on the relative efficacy of Marek's disease vaccines.
    Bacon LD; Witter RL
    Avian Dis; 1994; 38(1):65-71. PubMed ID: 8002902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective efficacy of Marek's disease virus (MDV) CVI-988 CEF65 clone C against challenge infection with three very virulent MDV strains.
    de Boer GF; Groenendal JE; Boerrigter HM; Kok GL; Pol JM
    Avian Dis; 1986; 30(2):276-83. PubMed ID: 3015113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus.
    Nazerian K; Witter RL; Lee LF; Yanagida N
    Avian Dis; 1996; 40(2):368-76. PubMed ID: 8790888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivation, safety and efficacy of a Marek's disease vaccine developed from an Australian isolate of very virulent Marek's disease virus.
    Karpathy RC; Firth GA; Tannock GA
    Aust Vet J; 2002; 80(1-2):61-6. PubMed ID: 12180882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Field trials with a bivalent vaccine (HVT and SB-1) against Marek's disease.
    Calnek BW; Schat KA; Peckham MC; Fabricant J
    Avian Dis; 1983; 27(3):844-9. PubMed ID: 6314982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotype 1 viruses modified by backpassage or insertional mutagenesis: approaching the threshold of vaccine efficacy in Marek's disease.
    Witter RL; Kreager KS
    Avian Dis; 2004 Dec; 48(4):768-82. PubMed ID: 15666858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of strong protection by vaccination with partially attenuated serotype 1 Marek's disease viruses.
    Witter RL
    Avian Dis; 2002; 46(4):925-37. PubMed ID: 12495054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a bivalent vaccine against Marek's disease.
    Pruthi AK; Gupta RK; Sadana JR
    Res Vet Sci; 1987 Mar; 42(2):145-9. PubMed ID: 3035660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial inhibition by turkey herpesvirus of serotype 2 Marek's disease virus plaque formation and in vivo infectivity.
    Witter RL; Bacon LD; Calvert JG
    Avian Dis; 1994; 38(4):800-9. PubMed ID: 7702514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a combination vaccine containing MDV CVI 988 strain and HVT against challenge with very virulent MDV.
    Geerligs HJ; Weststrate MW; Pertile TL; Rodenberg J; Kumar M; Chu S
    Acta Virol; 1999; 43(2-3):198-200. PubMed ID: 10696445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of four very virulent Argentinian strains of Marek's disease virus and the influence of one of those isolates on synergism between Marek's disease vaccine viruses.
    Buscaglia C; Nervi P; Risso M
    Avian Pathol; 2004 Apr; 33(2):190-5. PubMed ID: 15276986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral immune responses to inactivated oil-emulsified Marek's disease vaccine.
    Lee LF; Witter RL
    Avian Dis; 1991; 35(3):452-9. PubMed ID: 1659363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embryo vaccination against Marek's disease with serotypes 1, 2 and 3 vaccines administered singly or in combination.
    Sharma JM; Witter RL
    Avian Dis; 1983; 27(2):453-63. PubMed ID: 6307248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection by attenuated and polyvalent vaccines against highly virulent strains of Marek's disease virus.
    Witter RL
    Avian Pathol; 1982; 11(1):49-62. PubMed ID: 18770172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of Marek's disease: a review.
    Purchase HG
    Cancer Res; 1976 Feb; 36(2 pt 2):696-700. PubMed ID: 766959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.